Exousia Bio (LMMY) Total Liabilities (2022 - 2025)

Exousia Bio has disclosed Total Liabilities across 4 years of filings, most recently posting $261023.0 for Q4 2025.

• Total Liabilities for Q4 2025 came in at $261023.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was $261023.0 (changed N/A YoY), and the FY2024 annual result was $82348.0, up 24.52% from the prior year.
• Total Liabilities came in at $261023.0 for Q4 2025 at Exousia Bio, up from $35314.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $261023.0 in Q4 2025 to a low of $13408.0 in Q3 2022.
• The 4-year median for Total Liabilities is $67106.5 (2023), against an average of $75131.3.
• Across the five-year window, Total Liabilities soared 407.76% in 2023 and tumbled 59.3% in 2025, its largest moves.
• Exousia Bio's Total Liabilities stood at $21814.0 in 2022, then surged by 228.06% to $71564.0 in 2023, then climbed by 21.24% to $86764.0 in 2024, then jumped by 200.84% to $261023.0 in 2025.
• The last three Total Liabilities figures came in at $261023.0 (Q4 2025), $35314.0 (Q3 2025), and $86764.0 (Q3 2024), per Business Quant data.